Association between left ventricular function and paraprotein type in patients with multiple myeloma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Multiple myeloma (MM)–associated cardiac damage, particularly according to the type of monoclonal (M) protein has not been elucidated. We sought to investigate relationship between elevated serum M protein levels and echocardiographic indices of cardiac structure and function in patients with MM. Methods: We evaluated a total of 184 consecutive MM patients who underwent echocardiography for bone marrow pre-transplant screening. Serum levels of intact immunoglobulin M protein and free light chain kappa/lambda (FLC-κ/-λ) were measured. Results: One hundred thirty-nine patients were non-light chain MM (non-LCMM) and 45 patients belonged to LCMM. In patients with non-LCMM, significant correlations were found between serum M protein and left atrial volume index (LAVi; r = 0.720, p < 0.0001), E/e’ (r = 0.511, p < 0.0001), and systolic pulmonary arterial pressure (r = 0.485, p < 0.0001). In patients with LCMM, log-transformed FLC-λ (log-λ) was correlated with left ventricular ejection fraction (LVEF, r = –0.536, p = 0.010), left ventricular (LV) end-systolic dimension (r = 0.500, p = 0.018), and LV end-systolic volume (r = 0.444, p = 0.038). On multivariate analyses, hematocrit and serum M protein were independent predictors of LAVi in patients with non-LCMM. In patient with LCMM, FLC-λ isotype was only found to be an independent determinant of LVEF. Conclusions: An increase in serum M protein was associated with LV diastolic dysfunction, whereas an increase in serum FLC-λ concentration showed a negative correlation with the echocardiographic parameters of LV systolic function. These findings also suggest that serum M protein has different effects on LV function according to the type of paraproteins in patients with MM.
Abstract
Background/Aims: Multiple myeloma (MM)–associated cardiac damage, particularly according to the type of monoclonal (M) protein has not been elucidated. We sought to investigate relationship between elevated serum M protein levels and echocardiographic indices of cardiac structure and function in patients with MM. Methods: We evaluated a total of 184 consecutive MM patients who underwent echocardiography for bone marrow pre-transplant screening. Serum levels of intact immunoglobulin M protein and free light chain kappa/lambda (FLC-κ/-λ) were measured. Results: One hundred thirty-nine patients were non-light chain MM (non-LCMM) and 45 patients belonged to LCMM. In patients with non-LCMM, significant correlations were found between serum M protein and left atrial volume index (LAVi; r = 0.720, p < 0.0001), E/e’ (r = 0.511, p < 0.0001), and systolic pulmonary arterial pressure (r = 0.485, p < 0.0001). In patients with LCMM, log-transformed FLC-λ (log-λ) was correlated with left ventricular ejection fraction (LVEF, r = –0.536, p = 0.010), left ventricular (LV) end-systolic dimension (r = 0.500, p = 0.018), and LV end-systolic volume (r = 0.444, p = 0.038). On multivariate analyses, hematocrit and serum M protein were independent predictors of LAVi in patients with non-LCMM. In patient with LCMM, FLC-λ isotype was only found to be an independent determinant of LVEF. Conclusions: An increase in serum M protein was associated with LV diastolic dysfunction, whereas an increase in serum FLC-λ concentration showed a negative correlation with the echocardiographic parameters of LV systolic function. These findings also suggest that serum M protein has different effects on LV function according to the type of paraproteins in patients with MM.
참고문헌 (26)
- Kyle RA, "Multiple myeloma", N Engl J Med, 351, pp.1860~1873 (2004)
- Rajkumar SV, "Primary systemic amyloidosis with delayed progression to multiple myeloma", Cancer, 82, pp.1501~1505 (1998)
- Cueto-Garcia L, "Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival", J Am Coll Cardiol, 6, pp.737~743 (1985)
- International Myeloma Working Group., "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group", Br J Haematol, 121, pp.749~757 (2003)
- Dispenzieri A, "International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders", Leukemia, 23, pp.215~224 (2009)
- Lang RM, "Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology", J Am Soc Echocardiogr, 18, pp.1440~1463 (2005)
- Nagueh SF, "Recommendations for the evaluation of left ventricular diastolic function by echocardiography", J Am Soc Echocardiogr, 22, pp.107~133 (2009)
- Rudski LG, "Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography", J Am Soc Echocardiogr, 23, pp.685~713 (2010)
- Swain SM, "Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials", Cancer, 97, pp.2869~2879 (2003)
- Russell JA, "The relationship between serum viscosity, hypervolaemia and clinical manifestations associated with circulating paraprotein", Br J Haematol, 39, pp.163~175 (1978)
- Mehta J, "Hyperviscosity syndrome in plasma cell dyscrasias", Semin Thromb Hemost, 29, pp.467~471 (2003)
- Abhayaratna WP, "Left atrial size: physiologic determinants and clinical applications", J Am Coll Cardiol, 47, pp.2357~2363 (2006)
- Ommen SR, "Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures:a comparative simultaneous Doppler-catheterization study", Circulation, 102, pp.1788~1794 (2000)
- Firstenberg MS, "Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers", J Am Coll Cardiol, 36, pp.1664~1669 (2000)
- Somer T., "Rheology of paraproteinaemias and the plasma hyperviscosity syndrome", Baillieres Clin Haematol, 1, pp.695~723 (1987)
- Carr ME Jr, "Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma", Am J Physiol, 266(3 Pt 2), pp.H1195~H1201 (1994)
- Morsdorf S, "Haemostatical and rheological aspects of dysfibrinogenemia", Clin Hemorheol Microcirc, 17, pp.13~19 (1997)
- Baskurt OK, "Hemorheology and vascular control mechanisms", Clin Hemorheol Microcirc, 30, pp.169~178 (2004)
- Baskurt OK, "Blood rheology and hemodynamics", Semin Thromb Hemost, 29, pp.435~450 (2003)
- Liao R, "Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts", Circulation, 104, pp.1594~1597 (2001)
- Jimenez-Zepeda VH., "Light chain deposition disease: novel biological insights and treatment advances", Int J Lab Hematol, 34, pp.347~355 (2012)
- Schattner A, "Case report:multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis", Am J Med Sci, 310, pp.256~257 (1995)
- Garton MJ, "Systemic lambda lightchain deposition presenting with predominant cardiac involvement", Postgrad Med J, 69, pp.588~591 (1993)
- Shustik C, "Kappa and lambda light chain disease: survival rates and clinical manifestations", Blood, 48, pp.41~51 (1976)
- Ozsan GH, "Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias", Expert Rev Clin Immunol, 7, pp.65~73 (2011)
- Wan SH, "Pre-clinical diastolic dysfunction", J Am Coll Cardiol, 63, pp.407~416 (2014)